MIF and glioma: Although the low CD74 expression in the LN18 cells most likely account for the unresponsiveness to exogeneous MIF, a different glioma cell line not expressing CD74 has been found to still be responsive to recombinant MIF - arguing for an alternative MIF receptor [34].